FDA issues warning on use of azithromycin

03/13/2013 | Los Angeles Times (tiered subscription model) · Reuters

The FDA issued a warning that the antibiotic azithromycin, marketed as Zithromax or Zmax, could cause potentially fatal irregular heart rhythm in some patients. The agency said at-risk patients include those with a slower-than-normal heartbeat, with potassium or magnesium deficiencies, and those using medications to treat existing heart arrhythmia.

View Full Article in:

Los Angeles Times (tiered subscription model) · Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ